Outpatient thromboprophylaxis after hip or knee surgery: Discrepancies and concerns

CMAJ. Canadian Medical Association Journal

Volumn 178, Issue 12, 2008, Pages 1571-1572

  Fisher, William D ^a   Turpie, Alexander G G ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; EMBOLISM PREVENTION; HIGH RISK POPULATION; HIP SURGERY; KNEE SURGERY; MORTALITY; NOTE; OUTPATIENT; PATIENT COMPLIANCE; VENOUS THROMBOEMBOLISM; ECHOGRAPHY; EVIDENCE BASED MEDICINE; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; RISK FACTOR; TIME;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; EVIDENCE-BASED MEDICINE; HUMANS; OUTPATIENTS; RISK FACTORS; TIME FACTORS; VENOUS THROMBOEMBOLISM;

EID: 45549109632     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.080507     Document Type: Note

References (12)

1. Geerts WH. Pineo GF. Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:312-34.
2. Cardiovascular Disease Educational and Research Trust; Cyprus Cardiovascular Disease Educational and Research Trust; European Venous Forum; et al. Prevention and treatment of venous thromboembolism. International consensus statement (guidelines according to scientific evidence). Int Angiol 2006;25:101-61.
3. American Academy of Orthopaedic Surgeons clinical guidelines on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. Available: http://www.aaos.org/Research/guidelines/ PE_guideline.pdf (accessed 2008 Apr 25).
4. Leclerc JR, Geerts WH, Desjardins L, et al. Prevention of deep vein thrombosis after major knee surgery -a randomized double-blind trial comparing a low molecular heparin fragment (enoxaparin) to placebo. Thromb Haemost 1992;67:417-23.
5. Robinson KS, Anderson DR, Gross M, et al. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized controlled trial. Ann Intern Med 1997;127:439-45.
6. Rahme E, Dasgupta K, Burman M, et al. Postdischarge thromboprophylaxis and mortality risk after hip- or knee-replacement surgery. CMAJ 2008;178:1545-54.
7. Cohen AT, Tapson VF, Bergmann J-F, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371:387-94.
8. Dahl OE, Gudmundsen TE., Haukeland L. Late occurring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand 2000;71:47-50.
9. White BL, Fisher WD, Laurin CA. Rate of mortality for elderly patients after fracture of the hip in the 1980's. J Bone Joint Surg Am 1987;69:1335-40.
10. The Canadian Joint Replacement Registry 2007 Annual Report on Hip and Knee Replacements in Canada. Available: http://secure.cihi.ca/cihiweb/dispPage. jsp?cw_page=PG_835_E&cw_topic=835&cw_rel=AR_30_E (accessed 2008 May 2).
11. White RH, Romano PS, Zhou H, et al. Incidence and time course of thromboemblolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998;158:1525-31.
12. Gramse CA, Hingorani A, Ascher E. Postoperative anticoagulation in vascular surgery-part two: A summery of lessons learned in our successful discharge planning experience using enoxaparin after vascular surgery. J Vasc Nurs 2003;21:124-31.